Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Stock
Equities
600671
CNE000000BF3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.78 CNY | -0.11% | -1.24% | -24.70% |
Sales 2022 | 109M 15.04M | Sales 2023 | 122M 16.82M | Capitalization | 1.42B 196M |
---|---|---|---|---|---|
Net income 2022 | -67M -9.25M | Net income 2023 | -38M -5.25M | EV / Sales 2022 | 11.3 x |
Net Debt 2022 | 73.65M 10.17M | Net Debt 2023 | 16.8M 2.32M | EV / Sales 2023 | 11.8 x |
P/E ratio 2022 |
-17.3
x | P/E ratio 2023 |
-37.1
x | Employees | 371 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.72% |
1 day | -0.11% | ||
1 week | -1.24% | ||
1 month | -8.73% | ||
3 months | -13.67% | ||
6 months | -16.78% | ||
Current year | -24.70% |
Managers | Title | Age | Since |
---|---|---|---|
Xu Yu Xu
CEO | Chief Executive Officer | 46 | 23-09-26 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hua Cheng
BRD | Director/Board Member | 55 | 91-12-31 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 21-05-25 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 23-09-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 8.78 | -0.11% | 326,000 |
24-04-29 | 8.79 | -1.12% | 753,453 |
24-04-26 | 8.89 | +4.59% | 1,173,353 |
24-04-25 | 8.5 | +1.07% | 455,150 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-24.70% | 148M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600671 Stock